Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
agricultural and biological sciences
Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination
Food and Chemical Toxicology, Volume 48, No. 12, Year 2010
Notification
URL copied to clipboard!
Description
Micronuclei frequency is a sensitive biomarker used to evaluate the genotoxicity induced by xenobiotics. Pioglitazone and glimepiride were associated with genotoxicity in experimental studies conducted in rats. Considering the lack of published reports on genotoxicity in T2DM patients using pioglitazone and glimepiride drugs in combination, current study aimed to assess whether the case and control groups significantly differ from each other in the frequency of micronuclei. Subjects comprise 127 T2DM patients (35-65 years old) under pioglitazone and glimepiride treatment for >5 years and control group of 140 age matched healthy controls (38-69 years old). Exfoliated oral mucosa cells were collected from buccal mucosa of all subjects and Feulgen/Fast-Green method was followed to screen for micronuclei. Factors such as gender, food habits, living areas and occupation have not shown significant association with the variation in micronuclei frequency among the studied subjects. However, T2DM patients under long term treatment of pioglitazone and glimepiride in combination, showed increased frequency of micronuclei as compared to controls (p< 0.001). Current study suggests that the micronuclei assay can be used as a constituent among the panel of biomarkers to assess genotoxicity in T2DM patients under long term antihyperglycemic drug therapy. © 2010 Elsevier Ltd.
Authors & Co-Authors
Shaik, Noor Ahmad
India, Hyderabad
Osmania University
Saudi Arabia, Riyadh
King Saud University
Shaik, Jilani Purusottapatnam
India, Bhopal
Sofia College
India, Hyderabad
Shadan Institute for pg Studies
Saudi Arabia, Riyadh
King Saud University
Ali, Sharique
India, Bhopal
Sofia College
Imran, Ahamad
Saudi Arabia, Riyadh
King Saud University
Rao, Durga Koteswara
India, Hyderabad
Osmania University
Statistics
Citations: 43
Authors: 5
Affiliations: 4
Identifiers
Doi:
10.1016/j.fct.2010.09.016
ISSN:
02786915
Research Areas
Food Security
Health System And Policy
Noncommunicable Diseases
Study Design
Randomised Control Trial